- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00758238
Development and Pilot-Testing of a Patient Self Management Approach for Hypertension Using Personal Electronic Health Records (myBP)
September 23, 2008 updated by: Hamilton Health Sciences Corporation
Evidence-Based Development and Initial Evaluation of a Facilitated Patient Self Management e Health Strategy Intervention for Hypertension
The project includes a systematic review to inform refinement of intervention components and a pilot RCT to determine the uptake, feasibility, and potential value of a hypertension self-management strategy using personal health records.
The review follows generally acceptable systematic review and/or meta-analytic techniques; with specific attention devoted towards accessing information and effectiveness data from unpublished studies or reports within grey literature and contacting individuals with expertise in chronic disease management in primary care.
Findings of the review will be used to expand/modify an existing intervention 'template' to yield an evidence-based strategy with potential to enhance self-management of hypertension in primary care.
The pilot RCT will assess the utility of the multifaceted intervention, delivered in part via a secure patient-controlled personal electronic health record, compared with the usual family practice management, for patients with undiagnosed or uncontrolled elevated blood pressure.
Patients who are hypertensive or identified as high risk are expected to benefit from the increased flexibility and autonomy of out-of-physician-office self-monitoring with self-management support.
This initial evaluation will focus on the change in hypertension knowledge, patient self-efficacy, and patient engagement in self management activities after 3 months, in the intervention group compared to the control group; the feasibility and acceptability of the intervention to patients and providers; and the processes involved in linking the patient self-management experience back to the patient's health care providers to promote coordination of care.
Secondary outcomes include change in blood pressure, number and content of interactions with providers, and changes in management, including antihypertensive medication.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: David Chan, MD
- Phone Number: 905-575-9409
- Email: dchan@mcmaster.ca
Study Contact Backup
- Name: Tina Karwalajtys, PhD
- Phone Number: 28501 905-521-2100
- Email: karwalt@mcmaster.ca
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada
- Stonechurch Family Health Centre and McMaster Family Practice
-
Principal Investigator:
- David Chan, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Over 40 years of age
- Diagnosed with HTN, or being monitored for diagnosis, with a systolic BP >140 (SBP >130 mmHg if diabetes is diagnosed) at an office visit in the previous 6 months
- Own, borrow or be interested in purchasing a BP measurement device for home monitoring; or visit the clinic for self-assessment using the BpTRUTM (www.bptru.org)or monitor BP with a consistent device at a community pharmacy
- Regular access to email, to receive notices of new messages or prompts/reminders in MyOSCAR
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: myBP intervention
participants will receive access to hypertension self-management tools and support via a personal patient electronic health record
|
MyOSCAR, a web-based patient-controlled personal health record, provides a mechanism for patients to enter/track health information and can encourage longitudinal patient engagement, better interaction between patients and health care providers, and patient self management.
The intervention will provide access via MyOSCAR to a cardiovascular risk profile and BP tracker with sharing to providers enabled.
Patients can receive general information about hypertension management; tailored messages related to their modifiable risk factors; and secure messaging with multiple providers.
Providers can draw on a 'menu' of links/resources to share with patients.
A lifestyle changes planner/checklist and an enhanced medication diary are additional components.
|
No Intervention: usual care
participants allocated to usual care may still opt to use the personal patient electronic health record, but will not have access to the hypertension self-management tools until after the intervention period.
The usual care group will be given a web-link for patient hypertension management resources
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in hypertension knowledge, patient self-efficacy, and patient engagement in self management activities after 3 months, in the intervention group compared to the control group
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in blood pressure and antihypertensive medications
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Lisa Dolovich, PharmD, McMaster University
- Principal Investigator: David Chan, MD, McMaster University
- Principal Investigator: Tina Karwalajtys, PhD, McMaster University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2008
Primary Completion (Anticipated)
June 1, 2009
Study Completion (Anticipated)
September 1, 2009
Study Registration Dates
First Submitted
September 23, 2008
First Submitted That Met QC Criteria
September 23, 2008
First Posted (Estimate)
September 25, 2008
Study Record Updates
Last Update Posted (Estimate)
September 25, 2008
Last Update Submitted That Met QC Criteria
September 23, 2008
Last Verified
September 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 8-42213
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on myBP facilitated e-health self-management
-
Diakonhjemmet HospitalThe Norwegian Rheumatism AssociationActive, not recruiting
-
National University of SingaporeChangi General HospitalRecruitingHypertension | Diabetes Mellitus | HyperlipidemiasSingapore
-
McMaster UniversityHamilton Health Sciences Corporation; Canadian Cancer Society (CCS); Niagara...Not yet recruiting
-
IsalaActive, not recruitingMultiple SclerosisNetherlands
-
University of North Carolina, Chapel HillCenters for Disease Control and PreventionCompletedChronic DiseaseUnited States
-
Universitas Muhammadiyah YogyakartaNot yet recruitingQuality of Life | Cancer | Chemotherapy Effect | Self Efficacy
-
Morehouse School of MedicineEmory UniversityUnknownSelf-management | Cardiovascular HealthUnited States
-
Chang Gung Memorial HospitalCompletedGestational Diabetes Mellitus in PregnancyTaiwan
-
Universiti Teknologi MaraMinistry of Education, MalaysiaNot yet recruitingMetabolic Syndrome
-
University of Missouri-ColumbiaNational Institute on Aging (NIA)Active, not recruitingReducing COVID-19 Related Disability in Rural Community-Dwelling Older Adults Using Smart TechnologyQuality of Life | Disabilities MultipleUnited States